PTH and Marchiafava-Bignami disease: Consequently, vitamin D supplementation strategies—including dosing intensity and the use of active analogues—is increasingly guided by PTH, calcium, and phosphate levels, as recommended in the 2017 KDIGO CKD-MBD guidelines [2].